Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
ObjectiveUse of benzodiazepines and Z-drugs (non-benzodiazepine sedative hypnotics) is controversial due to adverse health outcomes in the general population. However, little is known about their use in people with multiple sclerosis (MS). We estimated the incidence and prevalence of benzodiazepine...
Main Authors: | Ruth Ann Marrie, John D. Fisk, Randy Walld, James M. Bolton, Jitender Sareen, Scott B. Patten, Alexander Singer, Lisa M. Lix, Carol A. Hitchon, Renée El-Gabalawy, Alan Katz, James J. Marriott, Charles N. Bernstein, the CIHR Team in Defining the Burden Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.874724/full |
Similar Items
-
Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data
by: Ruth Ann Marrie, et al.
Published: (2017-11-01) -
The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases.
by: Murray W Enns, et al.
Published: (2018-01-01) -
Sex differences evident in elevated anxiety symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis
by: Jerlin Joyees, et al.
Published: (2023-11-01) -
Support for a non-therapist assisted, Internet-based cognitive-behavioral therapy (iCBT) intervention for mental health in rheumatoid arthritis patients
by: Caitlin Blaney, et al.
Published: (2021-04-01) -
Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study
by: Scott B Patten, et al.
Published: (2023-06-01)